China cuts rates as economy slows; Credit Suisse chairman resigns over Covid-19 breaches - business live

Over the weekend GSK released new, higher organic sales growth forecasts for its consumer health division, which is a joint venture with Pfizer. It is planning to spin it off, and float on the stock market. GSK says: The Board of GSK therefore remains focused on executing its proposed demerger of the Consumer Healthcare business, to create a new independent global category-leading consumer company which, subject to approval from shareholders, is on track to be achieved in mid-2022. Unilever has confirmed that it approached GSK and Pfizer about a potential acquisition of the business, insisting that the deal would make…